The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics Evaluation and Research, the division that oversees vaccines and biologic ...

On first glance, Dr. Vinay Prasad’s medical credentials sound impressive. But look closer and you’ll find a narcissistic attention-seeker peddling misinformation, whose views will cost lives.

FDA Commissioner Marty Makary and CBER Director Vinay Prasad published an article in JAMA on Tuesday outlining the FDA’s ...

FDA Commissioner Marty Makary on Tuesday named Vinay Prasad the next director ... controlled studies for new vaccine approvals. Prasad’s appointment at CBER will likely continue to pressure ...

The appointment, announced May 6 by FDA Commissioner Dr. Marty Makary, places Prasad at the helm of one ... is precisely what the agency needs. “Vinay is willing to ask tough questions about ...

The FDA’s accelerated approval pathway plays a vital role, and scrapping it or reversing course on already-approved therapies ...

The FDA plans to “rapidly make available” rare disease drugs and make use of surrogate endpoints to get promising medicines ...

Vinay Prasad, a prominent critic of the pharmaceutical ... the job Prasad is stepping into has traditionally been held by an FDA career scientist. His appointment raises new questions about ...

A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.

FDA Commissioner Dr. Marty Makary and vaccine chief Dr. Vinay Prasad set stricter approval standards for booster shots ...